期刊文献+

糖代谢异常与肿瘤发生发展 被引量:7

Dysregulation of glucose metabolism in tumorigenesis and tumor progression
下载PDF
导出
摘要 细胞代谢异常和肿瘤发生发展密不可分,糖代谢异常在肿瘤代谢异常中表现得尤为突出。肿瘤细胞摄入大量葡萄糖,即使在供氧充足的情况下,也主要是通过糖酵解途径来产生能量和满足快速生长需求。糖代谢异常与肿瘤发生发展互为因果,肿瘤细胞代谢和信号转导网络互作来协同促进肿瘤发生发展。肿瘤相关基因的异常表达调控代谢网络,反之,异常的代谢酶或代谢物能够调控癌基因或抑癌蛋白。代谢酶作为细胞代谢的直接执行者,在肿瘤细胞糖代谢异常和肿瘤发生发展中发挥着关键作用。 Dysregulation of cell metabolism,especially glucose metabolism,is implicated in tumorigenesis and tumor progression. Cancer cells uptake a large amount of glucose and prefer to perform glycolysis in the cytosol even under normal oxygen condition,which fuels fast cell growth and proliferation. Dysregulation of glucose metabolism leads to tumorigenesis and promotes cancer development. Conversely,the initiation and development of cancer reprograms glucose metabolism to confer cancer cells the ability to survive and proliferate. Oncogenes,tumor suppressors or non-coding RNAs could regulate glucose metabolism. Meanwhile,the enzymes and metabolites involved in glucose metabolism could regulate the expression of factors related to cancer. Enzymes,the direct executor of cell metabolism,play a key role in dysregulation of glucose metabolism,tumorigenesis and tumor development.
出处 《中国生化药物杂志》 CAS 2016年第9期11-15,共5页 Chinese Journal of Biochemical Pharmaceutics
基金 国家重点基础研究发展计划(973计划 2015CB910401)
关键词 肿瘤 葡萄糖 代谢异常 糖酵解 tumor glucose dysregulation of cell metabolism glycolysis
  • 相关文献

参考文献2

二级参考文献60

  • 1Semenza GL and Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12: 5447-5454.
  • 2Wang GL, Jiang BH, Rue EA and Semenza GL. Hypoxia-inducible factor-I is a basic-helix-Ioop-helix-Pas heterodimer regulated by cellular 0-2 tension. Proc Natl Acad Sci USA 1995,92: 5510-5514.
  • 3Keith B, Johnson RS and Simon Me. HIFlalpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 2012, 12: 9-22.
  • 4Kaelin WG, Jr and Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008, 30: 393-402.
  • 5Semenza GL. Targeting HIF-I for cancer therapy. Nat Rev Cancer 2003, 3: 721-732.
  • 6Warburg O. On the origin of cancer cells. Science 1956, 123: 309-314.
  • 7Dang CV and Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999,24: 68-72.
  • 8Semenza GL. Defining the role of hypoxia-inducible factor I in cancer biology and therapeutics. Oncogene 2010, 29: 625-634.
  • 9Gordan JD, Thompson CB and Simon MC. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 2007, 12: 108-113.
  • 10Gleadle JM and Ratcliffe PJ. Induction of hypoxia-inducible factor-I, erythropoietin, vascular endothelial growth factor, and glucose transporter-I by hypoxia: evidence against a regulatory role for Src kinase. Blood 1997, 89: 503-509.

共引文献28

同被引文献52

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部